
Stryker (SYK) Stock Forecast & Price Target
Stryker (SYK) Analyst Ratings
Bulls say
Stryker is currently facing a slowing momentum in their product cycles, slower adoption in certain settings, and potential disruption from a recent cyberattack. However, the company has a strong competitive position in the market and potential for growth through market expansion and acquisitions. There is also a risk of lower-than-expected growth in certain procedure categories due to increased competition. Overall, while there are some challenges facing the company, there is potential for long-term growth and a positive outlook for the stock.
Bears say
Stryker is facing stiff competition in the market for orthopedic robotics systems, as several competitors are ramping up their own programs with new and differentiated products. Slow adoption within the ASC setting could limit the company's long-term growth potential, and the recent cyberattack could potentially have a material impact on the company's near-term results and outlook. There are also concerns about the potential for slowing momentum from recent product cycles, lack of execution in growth-accretive M&A, and tariff and macro headwinds. However, Stryker's leadership position in the orthopedic implant market, its strong growth potential in the MedSurg and Neurotechnology segment, and its consistently strong commercial execution could potentially help drive outperformance and multiple expansion in the future.
This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.
Stryker (SYK) Analyst Forecast & Price Prediction
Start investing in Stryker (SYK)
Order type
Buy in
Order amount
Est. shares
0 shares